Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
or
Long-term outcomes and circulating tumor DNA analysis from a phase I/II study of lenalidomide and obinutuzumab with CHOP for newly diagnosed diffuse large B-cell lymphoma.
ÌÇÐÄ´«Ã½
Long-term outcomes and circulating tumor DNA analysis from a phase I/II study of lenalidomide and obinutuzumab with CHOP for newly diagnosed diffuse large B-cell lymphoma. Cherng, H., Alig, S., Oki, Y., Nastoupil, L. J., Fayad, L., Neelapu, S., Turturro, F., Hagemeister, F. B., Rodriguez, M., McDonnell, T., Flowers, C., Vega, F., Green, M., Alizadeh, A. A., Davis, R., Westin, J. LIPPINCOTT WILLIAMS & WILKINS. 2022View details for